Terpene conjugates of diaminedichloridoplatinum(II) complexes: Antiproliferative effects in HL-60 Leukemia, 518A2 melanoma, and HT-29 colon cancer cells

Chemistry and Biodiversity

Volumn 5, Issue 8, 2008, Pages 1645-1659

  Bernhardt, Günther ^a   Biersack, Bernhard ^b   Bollwein, Susanne ^a   Schobert, Ramer ^b   Zoldakova, Miroslava ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIAMINOPROPANOATE COMPLEX; 1,3 DIAMINOBUTANOATE COMPLEX; 6 (AMINOMETHYL)NICONITIC ACID DICHLORIDOPLATINUM COMPLEX; ALCOHOL; ANTINEOPLASTIC AGENT; CISPLATIN; DIAMINEDICHLORIDOPLATINUM COMPLEX; DNA; LIGAND; MENTHOL; PLATINUM COMPLEX; SESQUITERPENE DERIVATIVE; TERPENE DERIVATIVE; UNCLASSIFIED DRUG; TERPENE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DRUG CONJUGATION; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG STRUCTURE; ELECTROPHORESIS; ESTERIFICATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; LEUKEMIA; MELANOMA; MELANOMA CELL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; CELL STRAIN HL 60; CELL STRAIN HT29; CHEMISTRY; CONFORMATION; DOSE RESPONSE; DRUG SCREENING; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; STANDARD; STEREOISOMERISM; SYNTHESIS; TIME; TUMOR CELL CULTURE;

CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HL-60 CELLS; HT29 CELLS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MELANOMA; MOLECULAR CONFORMATION; ORGANOPLATINUM COMPOUNDS; REFERENCE STANDARDS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TERPENES; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 58149280563     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200890152     Document Type: Article

References (27)

1. P. J. O'Dwyer, J. P. Stevenson, S. W. Johnson, Drugs 2000, 59, 19.
2. M. A. Jakupec, M. Galanski, B. K. Keppler, Rev. Physiol. Biochem. Pharmacol. 2003, 146, 1.
3. D. M. Kweekel, H. Gelderblom, H.-J. Guchelaar, Cancer Treatment Rev. 2005, 31, 90.
4. E. Wong, C. M. Giandomenico, Chem. Rev. 1999, 99, 2415.
5. E. R. Jamieson, S. J. Lippard, Chem. Rev. 1999, 99, 2467.
6. J. Reedijk, Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 3611.
7. R. Schobert, B. Biersack, A. Dietrich, A. Grotemeier, T. Müller, B. Kalinowski, S. Knauer, W. Voigt, R. Paschke, J. Med. Chem. 2007, 50, 1288.
8. D. Trombetta, F. Castelli, M. G. Sarpietro, V. Venuti, M. Cristani, C. Daniele, A. Saija, G. Mazzanti, G. Bissignano, Antimicrob. Agents Chemother. 2005, 49, 2474.
9. T. Yuri, N. Danbara, M. Tsujita-Kyutoku, Y. Kiyozuka, H. Senzaki, N. Shikata, H. Kanzaki, A. Tsubura, Breast Cancer Res. Tr. 2004, 84, 251.
10. I. R. Hardcastle, M. G. Rowlands, A. M. Barber, R. M. Grimshaw, M. K. Mohan, B. P. Nutley, M. Jarman, Biochem. Pharmacol. 1999, 57, 801.
11. S. A. Holstein, R. J. Hohl, J. Lipid Res. 2003, 44, 1209.
12. R. Schobert, B. Biersack, Inorg. Chim. Acta 2005, 358, 3369.
13. S. Moradell, J. Lorenzo, A. Rovira, S. van Zutphen, F. X. Aviles, V. Moreno, R. de Llorens, M. A. Martinez, J. Reedijk, A. Llobet, J. Inorg. Biochem. 2004, 98, 1933.
14. Y. Tsujimoto, S. Shimizu, Cell Death Differ. 2000, 7, 1174.
15. S. Shimizu, M. Narita, Y. Tsujimoto, Nature 1999, 399, 483.
16. E. Selzer, H. Schlagbauer-Wadl, I. Okamoto, H. Pehamberger, R. Potter, B. Jansen, Melanoma Res. 1998, 8(3), 197.
17. B. Jansen, V. Wacheck, E. Heere-Ress, H. Schlagbauer-Wadl, C. Hoeller, T. Lucas, M. Hoermann, U. Hollenstein, K. Wolff, H. Pehamberger, Lancet 2000, 356, 1728.
18. H.-F. Lu, S.-C. Hsueh, F.-S. Yu, J.-S. Yang, N.-Y. Tang, S.-C. Chen, J.-G. Chung, In ViVo 2006, 20, 69.
19. S. Thebault, L. Lemonnier, G. Bidaux, M. Flourakis, A. Bavenkoffe, D. Gordienko, M. Roudbaraki, P. Delcourt, Y. Panchin, Y. Shuba, R. Skryma, N. Prevarskaya, J. Biol. Chem. 2005, 280, 39423.
20. A. Séné, G. Bérubé, R. C. Gaudreault, Drug Des. Discov. 1998, 15, 277.
21. C. Descôteaux, J. Provencher-Mandeville, I. Mathieu, V. Perron, S. K. Mandal, E. Asselin, G. Bérubé, Bioorg. Med. Chem. Lett. 2003, 13, 3927.
22. R. Paschke, J. Kalbitz, C. Paetz, M. Luckner, T. Mueller, H.-J. Schmoll, H. Mueller, E. Sorkau, E. Sinn, J. Inorg. Biochem. 2003, 94, 335.
23. W. Voigt, A. Dietrich, H.-J. Schmoll, Pharm. Unserer Zeit 2006, 35, 134.
24. D. Gibson, K.-F. Gean, R. Ben-Shoshan, A. Ramu, I. Ringel, J. Katzhendler, J. Med. Chem. 1991, 34, 414.
25. R. Versteeg, I. A. Noordmeer, M. Krüse-Wolters, D. J. Ruiter, P. I. Schrier, EMBO J. 1988, 7(4), 1023.
26. G. Bernhardt, H. Reile, H. Birnbock, T. Spruss, S. Schonenberger, J. Cancer Res. Clin. Oncol. 1992, 118, 35.
27. M. A. Chowdhury, F. Huq, A. Abdullah, P. Bearle, K. Fisher, J. Inorg. Biochem. 2005, 99, 1098.